The DOI matches its Crossref record; 612 of the 615 references it cites were found in a registry or an index.
Cardiac fibrosis
Open accessAbstract
Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of extracellular matrix proteins, is a common pathophysiologic companion of many different myocardial conditions. Fibrosis may reflect activation of reparative or maladaptive processes. Activated fibroblasts and myofibroblasts are the central cellular effectors in cardiac fibrosis, serving as the main source of matrix proteins. Immune cells, vascular cells and cardiomyocytes may also acquire a fibrogenic phenotype under conditions of stress, activating fibroblast populations. Fibrogenic growth factors (such as transforming growth factor-β and platelet-derived growth factors), cytokines [including tumour necrosis factor-α, interleukin (IL)-1, IL-6, IL-10, and IL-4], and neurohumoral pathways trigger fibrogenic signalling cascades through binding to surface receptors, and activation of downstream signalling cascades. In addition, matricellular macromolecules are deposited in the remodelling myocardium and regulate matrix assembly, while modulating signal transduction cascades and protease or growth factor activity. Cardiac fibroblasts can also sense mechanical stress through mechanosensitive receptors, ion channels and integrins, activating intracellular fibrogenic cascades that contribute to fibrosis in response to pressure overload. Although subpopulations of fibroblast-like cells may exert important protective actions in both reparative and interstitial/perivascular fibrosis, ultimately fibrotic changes perturb systolic and diastolic function, and may play an important role in the pathogenesis of arrhythmias. This review article discusses the molecular mechanisms involved in the pathogenesis of cardiac fibrosis in various myocardial diseases, including myocardial infarction, heart failure with reduced or preserved ejection fraction, genetic cardiomyopathies, and diabetic heart disease. Development of fibrosis-targeting therapies for patients with myocardial diseases will require not only understanding of the functional pluralism of cardiac fibroblasts and dissection of the molecular basis for fibrotic remodelling, but also appreciation of the pathophysiologic heterogeneity of fibrosis-associated myocardial disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation and tissue fibrosis co-exist and are causally linked to organ dysfunction1,2.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [2]
In the citing paper
“Among stromal cell types, fibroblasts are of particular interest given their role in tissue fibrosis, arrhythmias, and heart failure 16,29,30 .”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [30]
Citations
Cites
Items 201–400 of 612
Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart Injury
Yokota, T., McCourt, J., Ma, F., Ren, S., Li, S., Kim, T.-H., Kurmangaliyev, Y. Z., Nasiri, R., Ahadian, S., Nguyen, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.030 · Cited by 209
Schellings, M. W. M., Vanhoutte, D., Swinnen, M., Cleutjens, J. P., Debets, J., van Leeuwen, R. E. W., d'Hooge, J., Van de Werf, F., Carmeliet, P., Pinto, Y. M., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081244 · Cited by 208
Rommel, K.-P., von Roeder, M., Latuscynski, K., Oberueck, C., Blazek, S., Fengler, K., Besler, C., Sandri, M., Lücke, C., Gutberlet, M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.018 · Cited by 208
Westermann, D., Linthout, S., Dhayat, S., Dhayat, N., Schmidt, A., Noutsias, M., Song, X.-Y., Spillmann, F., Riad, A., Schultheiss, H.-P., et al. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0673-0 · Cited by 207
Saxena, A., Dobaczewski, M., Rai, V., Haque, Z., Chen, W., Li, N., & Frangogiannis, N. G. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00328.2014 · Cited by 206
Self-citationDecreased Perivascular Fibrosis but Not Cardiac Hypertrophy in ROCK1 +/− Haploinsufficient Mice
Rikitake, Y., Oyama, N., Wang, C.-Y. C., Noma, K., Satoh, M., Kim, H.-H., & Liao, J. K. (2005) · Circulation · doi:10.1161/circulationaha.105.584623 · Cited by 205
Woodiwiss, A. J., Tsotetsi, O. J., Sprott, S., Lancaster, E. J., Mela, T., Chung, E. S., Meyer, T. E., & Norton, G. R. (2001) · Circulation · doi:10.1161/01.cir.103.1.155 · Cited by 204
Palmer, J. N., Hartogensis, W. E., Patten, M., Fortuin, F. D., & Long, C. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117956 · Cited by 203
Tenascin-C Regulates Recruitment of Myofibroblasts during Tissue Repair after Myocardial Injury
Tamaoki, M., Imanaka-Yoshida, K., Yokoyama, K., Nishioka, T., Inada, H., Hiroe, M., Sakakura, T., & Yoshida, T. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62954-9 · Cited by 202
Prognostic Value of Myocardial Infarct Size and Contractile Reserve Using Magnetic Resonance Imaging
Kelle, S., Roes, S. D., Klein, C., Kokocinski, T., de Roos, A., Fleck, E., Bax, J. J., & Nagel, E. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.027 · Cited by 202
Everett, R. J., Tastet, L., Clavel, M.-A., Chin, C. W. L., Capoulade, R., Vassiliou, V. S., Kwiecinski, J., Gomez, M., van Beek, E. J. R., White, A. C., et al. (2018) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.117.007451 · Cited by 202
Takemura, G., Ohno, M., Hayakawa, Y., Misao, J., Kanoh, M., Ohno, A., Uno, Y., Minatoguchi, S., Fujiwara, T., & Fujiwara, H. (1998) · Circulation Research · doi:10.1161/01.res.82.11.1130 · Cited by 201
Liao, C.-H., Akazawa, H., Tamagawa, M., Ito, K., Yasuda, N., Kudo, Y., Yamamoto, R., Ozasa, Y., Fujimoto, M., Wang, P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39942 · Cited by 201 · cited 1×
“overloaded hearts, PDGFR-a blockade reduced atrial fibrosis and protected from atrial fibrillation.(257) Although such effects likely reflect direct inhibition of PDGFR - a-driven fibroblast activation, actions on other cell types cannot be excluded.”
BackgroundXiang, F.-L., Fang, M., & Yutzey, K. E. (2017) · Nature Communications · doi:10.1038/s41467-017-00840-w · Cited by 201 · cited 2×
“Wntmediated fibroblast activation in the injured heart likely involves signalling through the b-catenin pathway.(267,268) Cell-specific genetic loss-offunction studies demonstrated that fibroblast-specific activation of b-catenin mediates both fibrosis and cardiomyocyte hypertrophy in the pressure-overloaded heart.”
BackgroundBujak, M., Kweon, H. J., Chatila, K., Li, N., Taffet, G., & Frangogiannis, N. G. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.011 · Cited by 199
Self-citationMyocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle.
Kolattukudy, P. E., Quach, T., Bergese, S. D., Breckenridge, S. M., Hensley, J., Altschuld, R. A., Gordillo, G. M., Klenotic, S. M., Orosz, C. G., & Parker‐Thornburg, J. (1998) · Europe PMC (PubMed Central) · Cited by 195
Matricellular proteins in the heart: possible role during stress and remodeling
SCHELLINGS, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.06.006 · Cited by 194
Right Ventricular Fibrosis: A Pathophysiological Factor in Pulmonary Hypertension?
Andersen, S., Nielsen-Kudsk, J. E., Vonk Noordegraaf, A., & de Man, F. S. (2019) · Circulation · doi:10.1161/circulationaha.118.035326 · Cited by 193
King, J. B., Azadani, P. N., Suksaranjit, P., Bress, A. P., Witt, D. M., Han, F. T., Chelu, M. G., Silver, M. A., Biskupiak, J., Wilson, B. D., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.758 · Cited by 192
López, B., Querejeta, R., González, A., Larman, M., & Díez, J. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196113 · Cited by 191
Bone marrow-derived cells contribute to infarct remodelling
MOLLMANN, H., NEF, H., KOSTIN, S., VONKALLE, C., PILZ, I., WEBER, M., SCHAPER, J., HAMM, C., & ELSASSER, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.013 · Cited by 191
Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy
Haudek, S. B., Cheng, J., Du, J., Wang, Y., Hermosillo-Rodriguez, J., Trial, J., Taffet, G. E., & Entman, M. L. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.05.005 · Cited by 190
CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response
Huebener, P., Abou-Khamis, T., Zymek, P., Bujak, M., Ying, X., Chatila, K., Haudek, S., Thakker, G., & Frangogiannis, N. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2625 · Cited by 189
Self-citationBrilla, C. G., Matsubara, L., & Weber, K. T. (1996) · Hypertension · doi:10.1161/01.hyp.28.2.269 · Cited by 188
Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis
Kong, P., Christia, P., Saxena, A., Su, Y., & Frangogiannis, N. G. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00395.2013 · Cited by 187
Self-citationRole of Osteopontin in Cardiac Fibrosis and Remodeling in Angiotensin II-Induced Cardiac Hypertrophy
Matsui, Y., Jia, N., Okamoto, H., Kon, S., Onozuka, H., Akino, M., Liu, L., Morimoto, J., Rittling, S. R., Denhardt, D., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000128621.68160.dd · Cited by 187
Stockand, J. D., & Meszaros, J. G. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00421.2002 · Cited by 187 · cited 1×
“In isolated cardiac fibroblasts, aldosterone triggers a proliferative response,(98) stimulates migration,(99) and promotes a matrix-synthetic phenotype,(100) at least in part through activation of MAPK cascades.(101) Whether these actions are re-”
BackgroundMyofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Nagaraju, C. K., Robinson, E. L., Abdesselem, M., Trenson, S., Dries, E., Gilbert, G., Janssens, S., Van Cleemput, J., Rega, F., Meyns, B., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.049 · Cited by 187 · cited 1×
“TGF-b induction and activation has been consistently demonstrated in several different models of cardiac fibrosis,(205,213,214) and in human hearts with fibrotic cardiomyopathic changes.(215,216) Although many different cell types (including macrophages, fibroblasts, cardiomyocytes, and platelets) can produce de novo…”
BackgroundKolodsick, J. E., Toews, G. B., Jakubzick, C., Hogaboam, C., Moore, T. A., McKenzie, A., Wilke, C. A., Chrisman, C. J., & Moore, B. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4068 · Cited by 185
Kulasekaran, P., Scavone, C. A., Rogers, D. S., Arenberg, D. A., Thannickal, V. J., & Horowitz, J. C. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0447oc · Cited by 185 · cited 1×
“resistance to apoptosis.(286) In a model of type 1 diabetes, ET-1-mediated”
BackgroundKumar, S., Wang, G., Zheng, N., Cheng, W., Ouyang, K., Lin, H., Liao, Y., & Liu, J. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12267 · Cited by 184
Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction
Ramjee, V., Li, D., Manderfield, L. J., Liu, F., Engleka, K. A., Aghajanian, H., Rodell, C. B., Lu, W., Ho, V., Wang, T., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88759 · Cited by 181
Extracellular matrix remodeling in canine and mouse myocardial infarcts
Dobaczewski, M., Bujak, M., Zymek, P., Ren, G., Entman, M. L., & Frangogiannis, N. G. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0144-6 · Cited by 180
Self-citationMacrophage Smad3 Protects the Infarcted Heart, Stimulating Phagocytosis and Regulating Inflammation
Chen, B., Huang, S., Su, Y., Wu, Y.-J., Hanna, A., Brickshawana, A., Graff, J., & Frangogiannis, N. G. (2019) · Circulation Research · doi:10.1161/circresaha.119.315069 · Cited by 180 · cited 11×
“Although myeloid cell-specific loss of Smad3 markedly attenuated TGF-b synthesis by macrophages, collagen deposition in the infarct and interstitial fibrosis in non-infarcted areas was not affected in a model of non-reperfused MI.243 5.4.2 Other members of the TGF-b superfamily Information on the role of other members…”
BackgroundInfluentialSelf-citationDynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation
Stratton, M. S., Bagchi, R. A., Felisbino, M. B., Hirsch, R. A., Smith, H. E., Riching, A. S., Enyart, B. Y., Koch, K. A., Cavasin, M. A., Alexanian, M., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315125 · Cited by 179
Gata6+ Pericardial Cavity Macrophages Relocate to the Injured Heart and Prevent Cardiac Fibrosis
Deniset, J. F., Belke, D., Lee, W.-Y., Jorch, S. K., Deppermann, C., Hassanabad, A. F., Turnbull, J. D., Teng, G., Rozich, I., Hudspeth, K., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.010 · Cited by 178
Aoki, T., Fukumoto, Y., Sugimura, K., Oikawa, M., Satoh, K., Nakano, M., Nakayama, M., & Shimokawa, H. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0568 · Cited by 177
Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction
Haider, N., Boscá, L., Zandbergen, H. R., Kovacic, J. C., Narula, N., González-Ramos, S., Fernandez-Velasco, M., Agrawal, S., Paz-García, M., Gupta, S., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.036 · Cited by 177
Edelmann, F., Holzendorf, V., Wachter, R., Nolte, K., Schmidt, A. G., Kraigher-Krainer, E., Duvinage, A., Unkelbach, I., Düngen, H.-D., Tschöpe, C., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.203 · Cited by 176
Asano, Y., Ihn, H., Yamane, K., Jinnin, M., & Tamaki, K. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.041306 · Cited by 175 · cited 1×
“Pericellular activation of TGF-b in sites of injury involves several different molecular signals, including proteases, matricellular proteins,(214,220) and integrins.(221) The relative contribution of specific TGF-b activating signals in the fibrotic heart has not been investigated.”
BackgroundTakawale, A., Zhang, P., Patel, V. B., Wang, X., Oudit, G., & Kassiri, Z. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09045 · Cited by 175
Analysis of healing after myocardial infarction using polarized light microscopy.
Whittaker, P., Boughner, D. R., & Kloner, R. A. (1989) · Europe PMC (PubMed Central) · Cited by 174
Naugle, J. E., Olson, E. R., Zhang, X., Mase, S. E., Pilati, C. F., Maron, M. B., Folkesson, H. G., Horne, W. I., Doane, K. J., & Meszaros, J. G. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00321.2005 · Cited by 174
Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice
Brooks, W. W., & Conrad, C. H. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1065 · Cited by 174 · cited 1×
“Heterozygous TGF-b1þ/- deficient mice had delayed interstitial fibrotic changes as they aged.(226) Moreover, mice with fibroblast-specific loss of the type I or type II TGF-b receptors (TbRI or TbRII) had reduced cardiac fibrosis in a model of left ventricular pressure overload(227) suggesting that fibrotic remodellin…”
BackgroundBlyszczuk, P., Müller-Edenborn, B., Valenta, T., Osto, E., Stellato, M., Behnke, S., Glatz, K., Basler, K., Lüscher, T. F., Distler, O., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw116 · Cited by 174
Noncoding RNAs and myocardial fibrosis
Thum, T. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.125 · Cited by 173
Cardiac Angiotensin II Type 2 Receptor Activates the Kinin/NO System and Inhibits Fibrosis
Kurisu, S., Ozono, R., Oshima, T., Kambe, M., Ishida, T., Sugino, H., Matsuura, H., Chayama, K., Teranishi, Y., Iba, O., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000050101.90932.14 · Cited by 173 · cited 1×
“In contrast, the type 2 receptor AT2 acts as a negative regulator of angiotensin II-mediated fibrogenic responses, inhibiting AT1 actions and suppressing fibroblast proliferation and matrix synthesis.(83,84)”
BackgroundOpposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium
Kong, P., Shinde, A. V., Su, Y., Russo, I., Chen, B., Saxena, A., Conway, S. J., Graff, J. M., & Frangogiannis, N. G. (2018) · Circulation · doi:10.1161/circulationaha.117.029622 · Cited by 173
Self-citationCarthy, J. M., Garmaroudi, F. S., Luo, Z., & McManus, B. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019809 · Cited by 172
Arslan, F., Smeets, M. B., Riem Vis, P. W., Karper, J. C., Quax, P. H., Bongartz, L. G., Peters, J. H., Hoefer, I. E., Doevendans, P. A., Pasterkamp, G., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.224428 · Cited by 172
Obesity-Related Heart Failure With a Preserved Ejection Fraction
Packer, M., & Kitzman, D. W. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.01.009 · Cited by 172
Iglarz, M., Touyz, R. M., Viel, É. C., Amiri, F., & Schiffrin, E. L. (2004) · American Journal of Hypertension · doi:10.1016/s0895-7061(04)00811-8 · Cited by 172
Williams, S. M., Golden-Mason, L., Ferguson, B. S., Schuetze, K. B., Cavasin, M. A., Demos-Davies, K., Yeager, M. E., Stenmark, K. R., & McKinsey, T. A. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.013 · Cited by 171
Monden, Y., Kubota, T., Inoue, T., Tsutsumi, T., Kawano, S., Ide, T., Tsutsui, H., & Sunagawa, K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00166.2007 · Cited by 170
Govindaraju, P., Todd, L., Shetye, S., Monslow, J., & Puré, E. (2019) · Matrix Biology · doi:10.1016/j.matbio.2018.06.004 · Cited by 170
Klingberg, F., Chau, G., Walraven, M., Boo, S., Koehler, A., Chow, M. L., Olsen, A. L., Im, M., Lodyga, M., Wells, R. G., et al. (2018) · Journal of Cell Science · doi:10.1242/jcs.201293 · Cited by 169
Cardiac Fibrosis and Arrhythmogenesis
Nguyen, M., Kiriazis, H., Gao, X., & Du, X. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160046 · Cited by 169
BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs
Borck, P. C., Guo, L., & Plutzky, J. (2020) · Circulation Research · doi:10.1161/circresaha.120.315929 · Cited by 169
The microRNA-15 family inhibits the TGFβ-pathway in the heart
Tijsen, A. J., van der Made, I., van den Hoogenhof, M. M., Wijnen, W. J., van Deel, E. D., de Groot, N. E., Alekseev, S., Fluiter, K., Schroen, B., Goumans, M.-J., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu184 · Cited by 167
Transcriptional heterogeneity of fibroblasts is a hallmark of the aging heart
Vidal, R., Wagner, J. U. G., Braeuning, C., Fischer, C., Patrick, R., Tombor, L., Muhly-Reinholz, M., John, D., Kliem, M., Conrad, T., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.131092 · Cited by 167
The Actin–MRTF–SRF Gene Regulatory Axis and Myofibroblast Differentiation
Small, E. M. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9397-0 · Cited by 165
Alex, L., Russo, I., Holoborodko, V., & Frangogiannis, N. G. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00238.2018 · Cited by 165
Self-citationBorer, J. S., Truter, S., Herrold, E. M., Falcone, D. J., Pena, M., Carter, J. N., Dumlao, T. F., Lee, J. A., & Supino, P. G. (2002) · Circulation · doi:10.1161/01.cir.0000014419.71706.85 · Cited by 164
Martínez-Martínez, E., Calvier, L., Fernández-Celis, A., Rousseau, E., Jurado-López, R., Rossoni, L. V., Jaisser, F., Zannad, F., Rossignol, P., Cachofeiro, V., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05876 · Cited by 163
Shi‐wen, X., Kennedy, L., Renzoni, E. A., Bou‐Gharios, G., du Bois, R. M., Black, C. M., Denton, C. P., Abraham, D. J., & Leask, A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23134 · Cited by 163
Cheng, T.-H., Cheng, P.-Y., Shih, N.-L., Chen, I.-B., Wang, D. L., & Chen, J.-J. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.06.010 · Cited by 163
Mercer, S. E., Odelberg, S. J., & Simon, H. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.08.002 · Cited by 163
Chen, S. N., Lombardi, R., Karmouch, J. L., Tsai, J.-Y., Czernuszewicz, G., Taylor, M. R. G., Mestroni, L., Coarfa, C., Gurha, P., & Marian, A. J. (2019) · Circulation Research · doi:10.1161/circresaha.118.314238 · Cited by 163
Integrins and integrin-related proteins in cardiac fibrosis
Chen, C., Li, R., Ross, R. S., & Manso, A. M. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.010 · Cited by 162
The role of inflammatory and fibrogenic pathways in heart failure associated with aging
Chen, W., & Frangogiannis, N. G. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9161-y · Cited by 161
Self-citationProteolytic control of growth factor availability
RIFKIN, D. B., MAZZIERI, R., MUNGER, J. S., NOGUERA, I., & SUNG, J. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01529.x · Cited by 161
Causes of nonischemic sudden cardiac death in the current era
Hookana, E., Junttila, M. J., Puurunen, V.-P., Tikkanen, J. T., Kaikkonen, K. S., Kortelainen, M.-L., Myerburg, R. J., & Huikuri, H. V. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.06.031 · Cited by 160
Role of TGF-β signaling in extracellular matrix production under high glucose conditions
Li, J., Huang, X. R., Zhu, H., Johnson, R. J., & Lan, H. Y. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00016.x · Cited by 160
Myocardial fibrosis predicts ventricular tachyarrhythmias
Disertori, M., Masè, M., & Ravelli, F. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.01.011 · Cited by 160
Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism
Jeong, M. Y., Lin, Y. H., Wennersten, S. A., Demos-Davies, K. M., Cavasin, M. A., Mahaffey, J. H., Monzani, V., Saripalli, C., Mascagni, P., Reece, T. B., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao0144 · Cited by 160
Lindsey, M. L., Iyer, R. P., Zamilpa, R., Yabluchanskiy, A., DeLeon-Pennell, K. Y., Hall, M. E., Kaplan, A., Zouein, F. A., Bratton, D., Flynn, E. R., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.035 · Cited by 159
Iglarz, M., Touyz, R. M., Viel, É. C., Amiri, F., & Schiffrin, E. L. (2004) · PubMed · Cited by 158
Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M
Abe, H., Takeda, N., Isagawa, T., Semba, H., Nishimura, S., Morioka, M. S., Nakagama, Y., Sato, T., Soma, K., Koyama, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10859-w · Cited by 158 · cited 1×
“Oncostatin M has been suggested to exert anti-fibrotic actions in the myocardium by inhibiting fibrogenic TGF-b signalling cascades.(191) Experimental studies in fibrotic responses of other organs have produced conflicting findings suggesting both pro-fibrotic(192) and anti-fibrotic effects(193) of oncostatin M.”
BackgroundPontén, A., Folestad, E. B., Pietras, K., & Eriksson, U. (2005) · Circulation Research · doi:10.1161/01.res.0000190590.31545.d4 · Cited by 157 · cited 1×
“In vivo, overexpression of PDGF-A or PDGF-D cause marked fibrotic cardiomyopathy associated with fibroblast activation.(254,255) PDGF isoforms and PDGFRs are up-regulated in fibrotic hearts(256) and have been implicated in the pathogenesis of fibrotic responses.”
BackgroundOsteopontin modulates angiotensin II- induced fibrosis in the intact murine heart
Collins, A. R., Schnee, J. M., Wang, W., Kim, S., Fishbein, M. C., Bruemmer, D., Law, R. E., Nicholas, S. B., Ross, R. S., & Hsueh, W. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.058 · Cited by 156
Xiao, Y., Hill, M. C., Li, L., Deshmukh, V., Martin, T. J., Wang, J., & Martin, J. F. (2019) · Genes & Development · doi:10.1101/gad.329763.119 · Cited by 156
Myocardial Fibrosis in DOCA-Salt Hypertensive Rats
Ammarguellat, F., Larouche, I., & Schiffrin, E. L. (2001) · Circulation · doi:10.1161/01.cir.103.2.319 · Cited by 155 · cited 1×
“In experimental animal models of hypertensive heart disease and of reparative myocardial fibrosis, ET-1 inhibition reduced fibrotic remodelling.(280,281)”
BackgroundMolecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart
Zhao, J., Randive, R., & Stewart, J. A. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.860 · Cited by 155
Cardiac Mast Cells Mediate Left Ventricular Fibrosis in the Hypertensive Rat Heart
Levick, S. P., McLarty, J. L., Murray, D. B., Freeman, R. M., Carver, W. E., & Brower, G. L. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123158 · Cited by 152
Nural, H. F., Zakharova, L., Nimlos, J., Popovic, S., Mastroeni, D., & Gaballa, M. A. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-10 · Cited by 152
Salvador, A. M., Nevers, T. A., Velázquez, F., Aronovitz, M. J., Wang, B., Abadía‐Molina, A. C., Jaffe, I. Z., Karas, R. H., Blanton, R. M., & Alcaide, P. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003126 · Cited by 150
CAMPBELL, S., Janicki, J., & Weber, K. T. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(95)90359-3 · Cited by 148 · cited 1×
“Extensive evidence suggests that aldosterone may play an important role in fibroblast activation following myocardial injury.(96,97) In isolated cardiac fibroblasts, aldosterone triggers a proliferative response,(98) stimulates migration,(99) and promotes a matrix-synthetic phenotype,(100) at least in part through act…”
BackgroundTranscriptional control of cardiac fibroblast plasticity
Lighthouse, J. K., & Small, E. M. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.016 · Cited by 148
Russo, I., Cavalera, M., Huang, S., Su, Y., Hanna, A., Chen, B., Shinde, A. V., Conway, S. J., Graff, J. M., & Frangogiannis, N. G. (2019) · Circulation Research · doi:10.1161/circresaha.118.314438 · Cited by 148
Self-citationDai, Z., Aoki, T., Fukumoto, Y., & Shimokawa, H. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.06.009 · Cited by 147
Duca, F., Kammerlander, A. A., Zotter‐Tufaro, C., Aschauer, S., Schwaiger, M. L., Marzluf, B. A., Bonderman, D., & Mascherbauer, J. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.005277 · Cited by 147
Xia, Y., Dobaczewski, M. P., González-Quesada, C. J., Chen, W., Biernacka, A., Li, N., Lee, D.-W., & Frangogiannis, N. G. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175323 · Cited by 146
Self-citationBastakoty, D., & Young, P. P. (2016) · The FASEB Journal · doi:10.1096/fj.201600502r · Cited by 143
Willeford, A., Suetomi, T., Nickle, A. C., Hoffman, H. M., Miyamoto, S., & Brown, J. H. (2018) · JCI Insight · doi:10.1172/jci.insight.97054 · Cited by 142
Iwanaga, Y., Aoyama, T., Kihara, Y., Onozawa, Y., Yoneda, T., & Sasayama, S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01756-4 · Cited by 141
Bradshaw, A. D., Baicu, C. F., Rentz, T. J., Laer, A. O. V., Boggs, J. M., Lacy, J. M., & Zile, M. R. (2009) · Circulation · doi:10.1161/circulationaha.108.773424 · Cited by 140
Turner, N. A. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00729-0 · Cited by 139
Extracellular matrix-derived peptides in tissue remodeling and fibrosis
Brás, L. E. D. C., & Frangogiannis, N. G. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.04.006 · Cited by 139
Self-citationMartos, R., Baugh, J. A., Ledwidge, M. T., O’Loughlin, C., Murphy, N. F., Conlon, C. M., Patle, A. K., Donnelly, S. C., & McDonald, K. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn036 · Cited by 138
Bujak, M., Dobaczewski, M. P., González-Quesada, C. J., Xia, Y., Leucker, T. M., Zymek, P. T., Veeranna, V., Tager, A. M., Luster, A. D., & Frangogiannis, N. G. (2009) · Circulation Research · doi:10.1161/circresaha.109.199471 · Cited by 138 · cited 1×
“Inhibition of fibrosis by CXCL10 may involve recruitment of yet unidentified leucocyte subsets that suppress fibroblast function, or direct de-activating effects on cardiac fibroblasts.(69,70) In vitro, CXCL10 was found to inhibit growth-factor-mediated fibroblast migration,(69) through interactions with proteoglycans…”
BackgroundSelf-citationRho Kinases and Cardiac Remodeling
Shimizu, T., & Liao, J. K. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0433 · Cited by 138
Shimojo, N., Hashizume, R., Kanayama, K., Hara, M., Suzuki, Y., Nishioka, T., Hiroe, M., Yoshida, T., & Imanaka‐Yoshida, K. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06004 · Cited by 137
Kim, J., Eckhart, A. D., Eguchi, S., & Koch, W. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204895200 · Cited by 137 · cited 1×
“fibroblasts have been attributed to epidermal growth factor receptor (EGFR) transactivation and downstream activation of ERK signalling.(115) The relative role of b1- and b2-AR responses in regulating the fibrotic”
BackgroundRegulation of myofibroblast activities: Calcium pulls some strings behind the scene
Castella, L. F., Gabbiani, G., McCulloch, C. A., & Hinz, B. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.033 · Cited by 137
González-Quesada, C. J., Cavalera, M., Biernacka, A., Kong, P., Lee, D.-W., Saxena, A., Frunza, O., Dobaczewski, M. P., Shinde, A. V., & Frangogiannis, N. G. (2013) · Circulation Research · doi:10.1161/circresaha.113.302593 · Cited by 135
Self-citationBiernacka, A., Cavalera, M., Wang, J., Russo, I., Shinde, A. V., Kong, P., González-Quesada, C. J., Rai, V., Dobaczewski, M. P., Lee, D.-W., et al. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001963 · Cited by 134
Self-citationOsteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
López, B., González, A., Lindner, D., Westermann, D., Ravassa, S., Beaumont, J., Gallego, I., Zudaire, A., Brugnolaro, C., Querejeta, R., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt100 · Cited by 132
Kruglov, E. A., Nathanson, R. A., Nguyễn, T. T., & Dranoff, J. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00308.2005 · Cited by 132
Epigenetics in Cardiac Fibrosis
Felisbino, M. B., & McKinsey, T. A. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.05.003 · Cited by 132
Sex-Related Differences in the Extent of Myocardial Fibrosis in Patients With Aortic Valve Stenosis
Tastet, L. L., Kwieciński, J., Pîbarot, P., Capoulade, R., Everett, R. J., Newby, D. E., Shen, M., Guzzetti, E., Arsenault, M., Bédard, É., et al. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.06.014 · Cited by 132
Post-infarct cardiac rupture: Recent insights on pathogenesis and therapeutic interventions
Gao, X., White, D. A., Dart, A. M., & Du, X. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.010 · Cited by 131 · cited 1×
“the structural integrity of the chamber, and in the case of a transmural infarction, preventing catastrophic mechanical complications, such as cardiac rupture.(4) In other cardiac diseases, fibrosis predominantly involves”
BackgroundPlakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes
Dubash, A. D., Kam, C. Y., Aguado, B. A., Patel, D. M., Delmar, M., Shea, L. D., & Green, K. J. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201507018 · Cited by 131
Cieslik, K. A., Taffet, G. E., Carlson, S., Hermosillo, J. A. G., Trial, J., & Entman, M. L. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.019 · Cited by 130 · cited 1×
“IL-13 can activate a matrix-synthetic programme in fibroblasts,(202) stimulating TGF-b expression and activation,(203) and may promote a fibrogenic phenotype in monocytes and macrophages.(201)”
BackgroundDewald, O., Frangogiannis, N. G., Zoerlein, M., Duerr, G. D., Klemm, C., Knuefermann, P., Taffet, G. E., Michael, L. H., Crapo, J. D., Welz, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438035100 · Cited by 130
Self-citationNishida, M., Onohara, N., Sato, Y., Suda, R., Ogushi, M., Tanabe, S., Inoue, R., Mori, Y., & Kurose, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611780200 · Cited by 130
Temporal Response and Localization of Integrins β1 and β3 in the Heart After Myocardial Infarction
Sun, M., Opavsky, M. A., Stewart, D. J., Rabinovitch, M., Dawood, F., Wen, W.-H., & Liu, P. P. (2003) · Circulation · doi:10.1161/01.cir.0000051363.86009.3c · Cited by 129
Bioactive extracellular matrix fragments in lung health and disease
Gaggar, A., & Weathington, N. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83147 · Cited by 129 · cited 1×
“Many forms of cardiac injury, including myocardial ischaemia and pressure overload, induce rapid release and activation of proteases that degrade the native ECM, generating bioactive peptides termed matrikines and matricryptins.(290,291) Matrikines are fragments of ECM macromolecules with biological properties distinc…”
BackgroundSeeland, U., Haeuseler, C., Hinrichs, R., Rosenkranz, S., Pfitzner, T., Scharffetter‐Kochanek, K., & Böhm, M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00985.x · Cited by 128
Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control
Nagatomo, Y., Carabello, B. A., Coker, M. L., McDermott, P. J., Nemoto, S., Hamawaki, M., & Spinale, F. G. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.1.h151 · Cited by 128
Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1
Park, J. B., & Schiffrin, E. L. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02291-9 · Cited by 127
Penn, M. S., Pastore, J., Miller, T. J., & Aras, R. A. (2012) · Gene Therapy · doi:10.1038/gt.2012.32 · Cited by 126 · cited 1×
“tory and progenitor cells, and in regulation of cardiomyocyte survival following injury.(144,145) Several studies have suggested that CXCL12 may exert fibrogenic actions through CXCR4 activation.”
BackgroundReduced Endoglin Activity Limits Cardiac Fibrosis and Improves Survival in Heart Failure
Kapur, N. K., Wilson, S., Yunis, A., Qiao, X., Mackey, E., Paruchuri, V., Baker, C., Aronovitz, M. J., Karumanchi, S. A., Letarte, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.080002 · Cited by 126
Vanhoutte, D., Schellings, M. W. M., Götte, M., Swinnen, M., Hérias, V., Wild, M. K., Vestweber, D., Chorianopoulos, E., Cortés, V., Rigotti, A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.644609 · Cited by 126
Endothelin-1 Stimulates Cardiac Fibroblast Proliferation Through Activation of Protein Kinase C
Piacentini, L., Gray, M. O., Honbo, N. Y., Chentoufi, J., Bergman, M. R., & Karliner, J. S. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1109 · Cited by 126
Kanagala, P., Cheng, A. S. H., Singh, A., Khan, J. N., Gulsin, G. S., Patel, P., Gupta, P., Arnold, J. R., Squire, I. B., Ng, L. L., et al. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.11.031 · Cited by 126
Syndecan-2 Regulates Transforming Growth Factor-β Signaling
Chen, L., Klass, C. M., & Woods, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300430200 · Cited by 125
Gurantz, D., Cowling, R. T., Varki, N. M., Frikovsky, E., Moore, C., & Greenberg, B. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.12.015 · Cited by 125 · cited 2×
“For example, pro-inflammatory cytokines may make fibroblasts more responsive to the effects of angiotensin II by inducing AT1 synthesis.(91) In”
BackgroundLuther, D. J., Thodeti, C. K., Shamhart, P. E., Adapala, R. K., Hodnichak, C. M., Weihrauch, D., Bonaldo, P., Chilian, W. M., & Meszaros, J. G. (2012) · Circulation Research · doi:10.1161/circresaha.111.252734 · Cited by 124
Leslie, K. O., Taatjes, D. J., Schwarz, J. E., vonTurkovich, M. A., & Low, R. B. (1991) · PubMed Central · Cited by 124
PDGF-A and PDGF-B induces cardiac fibrosis in transgenic mice
Gallini, R., Lindblom, P., Bondjers, C., Betsholtz, C., & Andræ, J. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.10.022 · Cited by 124 · cited 2×
“PDGF-B had only focal fibrotic changes, much less severe than PDGF-A overexpressing animals.(255) Neutralization of PDGFR-b signalilng in infarcted mice reduced collagen deposition, but had much more impressive effects in perturbation of vascular maturation, highlighting the significance of PDGFRb actions on vascular…”
BackgroundRickard, A. J., Morgan, J., Bienvenu, L. A., Fletcher, E. K., Cranston, G. A., Shen, J., Reichelt, M. E., Delbridge, L. M. D., & Young, M. J. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.203158 · Cited by 123
Belmadani, S., Bernal, J., Wei, C., Pallero, M. A., Dell’Italia, L. J., Murphy-Ullrich, J. E., & Berecek, K. H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070056 · Cited by 122
Biglycan Is Required for Adaptive Remodeling After Myocardial Infarction
Westermann, D., Mersmann, J., Melchior, A., Freudenberger, T., Petrik, C., Schaefer, L., Lüllmann‐Rauch, R., Lettau, O., Jacoby, C., Schrader, J., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.714147 · Cited by 122
Follistatin‐like 1 promotes cardiac fibroblast activation and protects the heart from rupture
Maruyama, S., Nakamura, K., Papanicolaou, K. N., Sano, S., Shimizu, I., Asaumi, Y., van den Hoff, M. J. B., Ouchi, N., Recchia, F. A., & Walsh, K. X. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506151 · Cited by 122 · cited 1×
“Follistatin-like 1 activated a reparative programme in infarct fibroblasts through ERK signalling and protected the infarcted ventricle from cardiac rupture.(249) In vitro studies have suggested that follistatin-like 3 may also have fibroblast-activating effects.”
BackgroundRosini, S., Pugh, N., Bonna, A., HULMES, D. J. S., Farndale, R. W., & Adams, J. C. (2018) · Science Signaling · doi:10.1126/scisignal.aar2566 · Cited by 122
Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
Turrini, P., Angelini, A., Thiene, G., Buja, G., Daliento, L., Rizzoli, G., & Nava, A. K. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00062-4 · Cited by 121
Venkatachalam, K., Venkatesan, B. A., Valente, A. J., Melby, P. C., Nandish, S., Reusch, J. E. B., Clark, R. A., & Chandrasekar, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809757200 · Cited by 121
Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis
Rios, F. J. O., Zou, Z., Harvey, A., Harvey, K. Y., Nosalski, R., Anyfanti, P., Camargo, L. L., Lacchini, S., Ryazanov, A. G., Ryazanova, L. V., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz164 · Cited by 119
Function and Therapeutic Potential of Noncoding RNAs in Cardiac Fibrosis
Creemers, E. E., & van Rooij, E. (2015) · Circulation Research · doi:10.1161/circresaha.115.305242 · Cited by 118
Small G Proteins in the Cardiovascular System: Physiological and Pathological Aspects
Loirand, G., Sauzeau, V., & Pacaud, P. (2013) · Physiological Reviews · doi:10.1152/physrev.00021.2012 · Cited by 118
Zhang, Y., Wang, J.-H., Zhang, Y.-Y., Wang, Y., Wang, J., Zhao, Y., Jin, X., Xue, G., Li, P.-H., Sun, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23010 · Cited by 117 · cited 9×
“effects of IL-6 have been attributed to STAT3-dependent stimulation of collagen synthesis by cardiac fibroblasts,(186) or to induction of TGF-b.(182)”
BackgroundInfluentialSyndecan-4 Prevents Cardiac Rupture and Dysfunction After Myocardial Infarction
Matsui, Y., Ikesue, M., Danzaki, K., Morimoto, J. O., Sato, M., Tanaka, S., Kojima, T., Tsutsui, H., & Uede, T. (2011) · Circulation Research · doi:10.1161/circresaha.110.235689 · Cited by 116
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
Chou, C., Hung, C., Liao, C., Wei, L., Chen, C., Shun, C., Wen, W.-F., Wan, C., Wu, X.-M., Chang, Y., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy013 · Cited by 116
Phrommintikul, A., Tran, L., Kompa, A. R., Wang, B. H., Adrahtas, A., Cantwell, D., Kelly, D. J., & Krum, H. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01078.2007 · Cited by 115
Zhang, W., Chancey, A. L., Tzeng, H.-P., Zhou, Z., Lavine, K. J., Gao, F., Sivasubramanian, N., Barger, P. M., & Mann, D. L. (2011) · Circulation · doi:10.1161/circulationaha.111.052399 · Cited by 115
Pressure-Independent Effects of Angiotensin II on Hypertensive Myocardial Fibrosis
Tokuda, K., Kai, H., Kuwahara, F., Yasukawa, H., Tahara, N., Kudo, H., Takemiya, K., Koga, M., Yamamoto, T., & Imaizumi, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000111831.50834.93 · Cited by 115
Morphometric investigation of human myocardium in arterial hypertension and valvular aortic stenosis
Schwartzkopff, B., Frenzel, H., Diekerhoff, J., Betz, P., Flaßhove, M., Schulte, H. D., Mundhenke, M., Motz, W., & Strauer, B. E. (1992) · European Heart Journal · doi:10.1093/eurheartj/13.suppl_d.17 · Cited by 115
Matsuda, M., Tsurusaki, S., Miyata, N., Saijou, E., Okochi, H., Miyajima, A., & Tanaka, M. (2017) · Hepatology · doi:10.1002/hep.29421 · Cited by 115
αv integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis
Murray, I. R., Gonzalez-Galofre, Z. N., Baily, J., Dobie, R., Wallace, R. J., MacKinnon, A. C., Smith, J. R., Greenhalgh, S. N., Thompson, A., Conroy, K. P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01097-z · Cited by 115
Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis
Kenneweg, F., Bang, C., Xiao, K., Boulanger, C. M., Loyer, X., Mazlan, S. M. I., Schroen, B. L. M., Hermans-Beijnsberger, S., Foinquinos, A., Hirt, M. N., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.003 · Cited by 115
Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction
Peng, H., Sarwar, Z., Yang, X.-P., Peterson, E. L., Xu, J., Janic, B., Rhaleb, N., Carretero, O. A., & Rhaleb, N. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05627 · Cited by 114 · cited 3×
“197 In a model of angiotensin II infusion, genetic loss of IL-4 reduced collagen deposition in the myocardium by 60%.198 Moreover, in a model of pressure overload induced through TAC, IL-4 neutralization attenuated fibrotic changes.199 IL-4 may exert direct fibrogenic actions by stimulating collagen synthesis in cardi…”
BackgroundInfluentialZhou, Y., Poczatek, M. H., Berecek, K. H., & Murphy-Ullrich, J. E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.060 · Cited by 114 · cited 8×
“The fibrogenic effects of TNF-a, IL-1, and IL-6 may involve direct actions on fibroblasts, or indirect effects, related to recruitment of macrophages, induction of matricellular proteins and up-regulation of growth factors with prominent fibroblast-activating properties, such as TGF-b.”
BackgroundInfluentialLI, J., LOTHARSCHWIMMBECK, P., Tschöpe, C., Leschka, S., Husmann, L., Rutschow, S., REICHENBACH, F., Noutsias, M., Kobalz, U., & Poller, W. C. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00546-1 · Cited by 114
HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction
Wallner, M., Eaton, D., Berretta, R. M., Liesinger, L., Schittmayer, M., Gindlhuber, J., Wu, J., Jeong, M. Y., Lin, Y. H., Borghetti, G., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay7205 · Cited by 114
Frangogiannis, N. G., Mendoza, L. H., Lewallen, M., Michael, L. H., Smith, C. W., & Entman, M. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-0745fje · Cited by 113 · cited 1×
“Inhibition of fibrosis by CXCL10 may involve recruitment of yet unidentified leucocyte subsets that suppress fibroblast function, or direct de-activating effects on cardiac fibroblasts.(69,70) In vitro, CXCL10 was found to inhibit growth-factor-mediated fibroblast migration,(69) through interactions with proteoglycans…”
BackgroundSelf-citationSiddesha, J. M., Valente, A. J., Sakamuri, S. S. V. P., Yoshida, T., Gardner, J. D., Somanna, N. K., Takahashi, C., Noda, M., & Chandrasekar, B. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.09.015 · Cited by 113
Awad, A., Kandalam, V., Chakrabarti, S., Wang, X., Penninger, J. M., Davidge, S. T., Oudit, G. Y., & Kassiri, Z. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00351.2009 · Cited by 113
Datta, R., Bansal, T., Rana, S., Datta, K., Chaudhuri, R. D., Chawla‐Sarkar, M., & Sarkar, S. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00611-16 · Cited by 113
Gonzalez, G. E., Rhaleb, N., D’Ambrosio, M. A., Nakagawa, P., Liu, Y., Leung, P., Dai, X., Yang, X.-P., Peterson, E. L., & Carretero, O. A. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000358 · Cited by 112
Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration
Rybarczyk, B. J., Lawrence, S. O., & Simpson‐Haidaris, P. J. (2003) · Blood · doi:10.1182/blood-2003-03-0822 · Cited by 111
Active interstitial remodeling: an important process in the hibernating human myocardium
Frangogiannis, N. G., Shimoni, S., Chang, S.-M., Ren, G., Dewald, O., Gersch, C. M., Shan, K., Aggeli, C., Reardon, M. J., Letsou, G. V., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01792-8 · Cited by 110 · cited 1×
“In human patients with ischaemic cardiomyopathy undergoing aortocoronary bypass surgery, highly cellular interstitial fibrosis, characterized by increased inflammatory activity, and higher levels of the matricellular protein tenascin-C was associated with more dynamic lesions and with an increased likelihood of recove…”
BackgroundSelf-citationArrhythmogenic consequences of myofibroblast–myocyte coupling
Nguyen, T. P., Xie, Y., Garfinkel, A., Qu, Z., & Weiss, J. N. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr292 · Cited by 109
Roy, C., Slimani, A., de Meester, C., Amzulescu, M., Pasquet, A., Vancraeynest, D., Beauloye, C., Vanoverschelde, J.-L., Gerber, B. L., & Pouleur, A.-C. (2018) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-018-0477-4 · Cited by 109
Mast cells and macrophages in normal C57/BL/6 mice
Gersch, C. M., Dewald, O., Zoerlein, M., Michael, L. H., Entman, M. L., & Frangogiannis, N. G. (2002) · Histochemistry and Cell Biology · doi:10.1007/s00418-002-0425-z · Cited by 108
Self-citationSyndecan-1 regulates αvβ5 integrin activity in B82L fibroblasts
McQuade, K. J., Beauvais, D. M., Burbach, B. J., & Rapraeger, A. C. (2006) · Journal of Cell Science · doi:10.1242/jcs.02970 · Cited by 108
Reversible and irreversible differentiation of cardiac fibroblasts
Driesen, R. B., Nagaraju, C. K., Abi-Char, J., Coenen, T., Lijnen, P. J., Fagard, R. H., Sipido, K. R., & Petrov, V. V. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt338 · Cited by 107
Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy
Sivakumar, P., Gupta, S., Sarkar, S., & Sen, S. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9595-2 · Cited by 107
Zhang, Z.-Z., Wang, W., Jin, H., Chen, X., Cheng, Y., Xu, Y., Song, B., Penninger, J. M., Oudit, G. Y., & Zhong, J. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10156 · Cited by 107
Blocking the IL-1β signalling pathway prevents chronic viral myocarditis and cardiac remodeling
Kraft, L., Erdenesukh, T., Sauter, M., Tschöpe, C., & Klingel, K. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0719-0 · Cited by 107
Hokimoto, S., Yasue, H., Fujimoto, K., Yamamoto, H., Nakao, K., Kaikita, K., Sakata, R., & Miyamoto, E. (1996) · Circulation · doi:10.1161/01.cir.94.7.1513 · Cited by 106
Aldosterone and d -Glucose Stimulate the Proliferation of Human Cardiac Myofibroblasts In Vitro
Neumann, S., Huse, K., Semrau, R., Diegeler, A., Gebhardt, R., Buniatian, G. H., & Scholz, G. H. (2002) · Hypertension · doi:10.1161/hy0302.105295 · Cited by 106
Clemente, C. F. M. Z., Tornatore, T. F., Theizen, T. H., Deckmann, A. C., Pereira, T. C., Lopes‐Cendes, Í., Matos‐Souza, J. R., & Franchini, K. G. (2007) · Circulation Research · doi:10.1161/circresaha.107.160978 · Cited by 106
Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload
Byun, J., Re, D. P. D., Zhai, P., Ikeda, S., Shirakabe, A., Mizushima, W., Miyamoto, S., Brown, J. H., & Sadoshima, J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006123 · Cited by 106
Frunza, O., Russo, I., Saxena, A., Shinde, A. V., Humeres, C. D., Hanif, W., Rai, V., Su, Y., & Frangogiannis, N. G. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.12.017 · Cited by 105
Self-citationChen, Z., Xie, J., Hao, H., Lin, H., Wang, L., Zhang, Y., Chen, L. Y., Cao, S., Huang, X., Liao, W., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx001 · Cited by 105
TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis
Duerrschmid, C., Crawford, J. R., Reineke, E. L., Taffet, G. E., Trial, J., Entman, M. L., & Haudek, S. B. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.01.006 · Cited by 104 · cited 1×
“endogenous TNF-a in the pathogenesis of fibrosis induced through pressure overload(157,163) through actions involving the type 1 TNF receptor (TNFR1).(161)”
BackgroundKoyanagi, M., Egashira, K., Kitamoto, S., Ni, W., Shimokawa, H., Takeya, M., Yoshimura, T., & Takeshita, A. (2000) · Circulation · doi:10.1161/01.cir.102.18.2243 · Cited by 104 · cited 1×
“diomyopathy, pressure overload-induced myocardiac remodelling and inflammatory heart diseases (Table 1).(125,126,129) The fibrogenic actions of”
BackgroundKrum, H., Elsik, M., Schneider, H. G., Ptaszynska, A., Black, M. J., Carson, P. E., Michel Komajda, N., Massie, B. M., McKelvie, R. S., McMurray, J. J. V., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.960716 · Cited by 104
Woodall, M. C., Woodall, B. P., Gao, E., Yuan, A., & Koch, W. J. (2016) · Circulation Research · doi:10.1161/circresaha.116.309538 · Cited by 103 · cited 11×
“Although myeloid cell-specific loss of Smad3 markedly attenuated TGF-b synthesis by macrophages, collagen deposition in the infarct and interstitial fibrosis in non-infarcted areas was not affected in a model of non-reperfused MI.243 5.4.2 Other members of the TGF-b superfamily Information on the role of other members…”
BackgroundInfluentialKong, P., González-Quesada, C. J., Li, N., Cavalera, M., Lee, D.-W., & Frangogiannis, N. G. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00006.2013 · Cited by 103
Self-citationMolecular profiling of dilated cardiomyopathy that progresses to heart failure
Burke, M. A., Chang, S., Wakimoto, H., Gorham, J., Conner, D. A., Christodoulou, D. C., Parfenov, M. G., DePalma, S. R., Eminaga, S., Konno, T., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86898 · Cited by 103
González, A., López, B., Ravassa, S., José, G. S., & Díez, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.06.001 · Cited by 103
Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts
Zhao, T., Zhao, W., Chen, Y., Li, V. S., Meng, W., & Sun, Y. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00130.2013 · Cited by 102 · cited 1×
“In vitro, PDGF-A and PDGFD potently stimulate cardiac fibroblast proliferation and ECM protein synthesis.(252,253) In vivo, overexpression of PDGF-A or PDGF-D cause marked fibrotic cardiomyopathy associated with fibroblast activation.”
BackgroundLombardi, R., Chen, S. N., Ruggiero, A., Gurha, P., Czernuszewicz, G. Z., Willerson, J. T., & Marian, A. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.308136 · Cited by 102
Tomasek, J. J., McRae, J., Owens, G. K., & Haaksma, C. J. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62353-x · Cited by 101
Fibroblasts and the extracellular matrix in right ventricular disease
Frangogiannis, N. G. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx146 · Cited by 101
Self-citationRho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation
Haudek, S. B., Gupta, D., Dewald, O., Schwartz, R. J., Wei, L., Trial, J., & Entman, M. L. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp135 · Cited by 100
Bone Marrow-Derived Cells Contribute to Fibrosis in the Chronically Failing Heart
Chu, P., Mariani, J. A., Finch, S., McMullen, J. R., Sadoshima, J., Marshall, T., & Kaye, D. M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090574 · Cited by 100
Kania, G., Błyszczuk, P., Stein, S., Valaperti, A., Germano, D., Dirnhofer, S., Hunziker, L., Matter, C., & Eriksson, U. (2009) · Circulation Research · doi:10.1161/circresaha.109.196287 · Cited by 100
Regulation of adverse remodelling by osteopontin in a genetic heart failure model
Psarras, S., Mavroidis, M., Sanoudou, D., Davos, C. H., Xanthou, G., Varela, A., Panoutsakopoulou, V., & Capetanaki, Y. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr119 · Cited by 100
Endothelium-mediated contributions to fibrosis
Sun, X., Nkennor, B., Mastikhina, O., Soon, K., & Nunes, S. S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.10.015 · Cited by 100 · cited 1×
“smooth muscle cells may also secrete molecular signals that regulate fibroblast behaviour.(66) Cardiomyocytes are also highly sensitive to micro-”
BackgroundChemokines and cardiac fibrosis
Frangogiannis, N. G. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s33 · Cited by 99 · cited 1×
“may directly modulate fibroblast phenotype and function, the in vivo significance of these effects in cardiac fibrotic remodelling remains unclear.(123)”
BackgroundSelf-citationAdiarto, S., Heiden, S., Vignon‐Zellweger, N., Nakayama, K., Yagi, K., Yanagisawa, M., & Emoto, N. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.02.006 · Cited by 99
Zheng, J., Chen, Y., Pat, B., Dell’Italia, L. A., Tillson, M., Dillon, A. R., Powell, P. C., Shi, K., Shah, N., Denney, T. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.826230 · Cited by 99
Hofmann, U., Knörr, S., Vogel, B., Weirather, J., Frey, A., Ertl, G., & Frantz, S. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.001020 · Cited by 99
Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy
Diny, N. L., Baldeviano, G. C., Talor, M. V., Barin, J. G., Ong, S., Bedja, D., Hays, A. G., Gilotra, N. A., Coppens, I., Rose, N. R., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161702 · Cited by 99 · cited 2×
“In myocarditis, eosinophils may be an additional major source of IL-4.”
BackgroundSevere Myocardial Fibrosis Caused by a Deletion of the 5’ End of the Lamin A/C Gene
van Tintelen, J. P., Tio, R. A., Kerstjens‐Frederikse, W. S., van Berlo, J. H., Boven, L. G., Suurmeijer, A. J. H., White, S. J., den Dunnen, J. T., Meerman, G. J. T., Vos, Y. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.063 · Cited by 98
Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation
Adam, O., Theobald, K., Lavall, D., Grube, M., Kroemer, H. K., Ameling, S., Schäfers, H., Böhm, M., & Laufs, U. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.019 · Cited by 98
Valero‐Muñoz, M., Li, S. J., Wilson, R. M., Boldbaatar, B., Iglarz, M., & Sam, F. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003381 · Cited by 98
Extracellular Matrix in Ischemic Heart Disease, Part 4/4
Frangogiannis, N. G., & Kovacic, J. C. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.020 · Cited by 97 · cited 1×
“In a protease-rich environment, all constituents of the cardiac ECM, (including collagens I, IV, and XVIII, elastin, fibronectin, hyaluronan, and tenascin-C) can generate fragments.(288,293) Most of the evidence on”
BackgroundSelf-citation
Cited by
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
“Cardiac fibroblast can sense mechanical cues through mechanosensitive receptors, and channels, hence promoting intracellular fibrogenic signaling.(634) Previous studies demonstrated that cyclic stretch promotes fibroblast activation and FMT.”
BackgroundMacrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 349
Antar, S. A., Ashour, N. A., Marawan, M. E., & Al-Karmalawy, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044004 · Cited by 366
“Cardiac fibrosis is an aberrant thickening of the heart valves caused by unsuitable fibroblast proliferation, but it is more frequently used to describe the excessive deposition of ECM in the cardiac muscle, as described in Figure 12 [123].”
BackgroundGoette, A., Corradi, D., Dobrev, D., Aguinaga, L., Cabrera, J.-A., Chugh, S. S., de Groot, J. R., Soulat-Dufour, L., Fenelon, G., Hatem, S. N., et al. (2024) · Europace · doi:10.1093/europace/euae204 · Cited by 310
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Metadata
- Authors
- Frangogiannis, N. G.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Frangogiannis, Nikolaos G
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-02
- Volume
- 117
- Issue
- 6
- Pages
- 1450-1488
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC8152700
- OpenAlex
- W4210607007
- Cited by
- 1,229
- References
- 615
- Citations by year
- 2026: 265 · 2025: 319 · 2024: 273 · 2023: 210 · 2022: 130 · 2021: 32
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Cardiovascular Research (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH (R01 HL76246, R01 HL85440, R01 HL149407)
- U.S. Department of Defense (PR151134, PR151029, PR181464)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- myocardial fibrosis, myocardial fibroblasts, myofibroblasts, extracellular matrix deposition, TGF-beta, platelet-derived growth factor, cytokines, mechanoreceptors, integrins, pressure overload, myocardial infarction, heart failure, familial cardiomyopathy, diabetic cardiomyopathy, cardiac arrhythmias
- MeSH terms
- Antifibrotic Agents, Animals, Extracellular Matrix, Fibroblasts, Fibrosis, Humans, Cardiomyopathies, Myocytes, Cardiac, Mechanotransduction, Cellular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.